BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 8880099)

  • 1. ICAM-1 expression by lung cancer cell lines: effects of upregulation by cytokines on the interaction with LAK cells.
    Melis M; Spatafora M; Melodia A; Pace E; Gjomarkaj M; Merendino AM; Bonsignore G
    Eur Respir J; 1996 Sep; 9(9):1831-8. PubMed ID: 8880099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of intercellular adhesion molecule 1 on small cell lung carcinoma cell lines by gamma-interferon enhances spontaneous and bispecific anti-CD3 x antitumor antibody-directed lymphokine activated killer cell cytotoxicity.
    Azuma A; Yagita H; Matsuda H; Okumura K; Niitani H
    Cancer Res; 1992 Sep; 52(18):4890-4. PubMed ID: 1381273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intercellular adhesion molecule-1 expression by bladder cancer cells: functional effects.
    Campbell SC; Tanabe K; Alexander JP; Edinger M; Tubbs RR; Klein EA
    J Urol; 1994 May; 151(5):1385-90. PubMed ID: 7908992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of leukemic cell sensitivity to lymphokine-activated killer cytolysis: role of intercellular adhesion molecule-1.
    Triozzi PL; Eicher DM; Smoot J; Rinehart JJ
    Exp Hematol; 1992 Oct; 20(9):1072-6. PubMed ID: 1361453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interferon gamma but not tumor necrosis factor alpha decreases susceptibility of human renal cell cancer cell lines to lymphokine-activated killer cells.
    Tomita Y; Watanabe H; Kobayashi H; Nishiyama T; Tsuji S; Fujiwara M; Sato S
    Cancer Immunol Immunother; 1992; 35(6):381-7. PubMed ID: 1356627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Celecoxib increases lung cancer cell lysis by lymphokine-activated killer cells via upregulation of ICAM-1.
    Schellhorn M; Haustein M; Frank M; Linnebacher M; Hinz B
    Oncotarget; 2015 Nov; 6(36):39342-56. PubMed ID: 26513172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytokine regulation of cell-to-cell interactions in lymphokine-activated killer cell cytotoxicity in vitro.
    Takahashi T; Ishikura H; Iwai K; Takahashi C; Kato H; Tanabe T; Yoshiki T
    Cancer Immunol Immunother; 1993; 36(2):76-82. PubMed ID: 8093857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cannabinoids increase lung cancer cell lysis by lymphokine-activated killer cells via upregulation of ICAM-1.
    Haustein M; Ramer R; Linnebacher M; Manda K; Hinz B
    Biochem Pharmacol; 2014 Nov; 92(2):312-25. PubMed ID: 25069049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased susceptibility of IFN-gamma-treated neuroblastoma cells to lysis by lymphokine-activated killer cells: participation of ICAM-1 induction on target cells.
    Naganuma H; Kiessling R; Patarroyo M; Hansson M; Handgretinger R; Grönberg A
    Int J Cancer; 1991 Feb; 47(4):527-32. PubMed ID: 1671670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ICAM-1 and LFA-3 enhance the ability of anti-CD3 mAb to stimulate interferon gamma production in interleukin-2-activated T cells.
    Chong AS; Jiang XL; Scuderi P; Lamas M; Graf LH
    Cancer Immunol Immunother; 1994 Aug; 39(2):127-34. PubMed ID: 7519126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human small-cell lung-cancer cells are cytokine-resistant but NK/LAK-sensitive.
    Lagadec PF; Saraya KA; Balkwill FR
    Int J Cancer; 1991 May; 48(2):311-7. PubMed ID: 1850388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytokine modulation of interactions between cultured human renal tubular and lymphoid blast cells.
    Takahashi C; Ishikura H; Chikaraishi T; Koyanagi T; Yoshiki T
    Pathol Res Pract; 1995 Feb; 191(1):1-7. PubMed ID: 7651927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Membrane-associated lymphotoxin-expressing lymphokine-activated killer cells up-regulate intercellular adhesion molecule-1 expression on target tumor cells in vitro.
    Kimura K; Abe Y; Horiuchi A; Miyake M; Kimura S
    Cell Immunol; 1995 Aug; 164(1):119-25. PubMed ID: 7634343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased expression of ICAM-1 and its induction by tumor necrosis factor on breast-cancer cells in vitro.
    Budinsky AC; Brodowicz T; Wiltschke C; Czerwenka K; Michl I; Krainer M; Zielinski CC
    Int J Cancer; 1997 Jun; 71(6):1086-90. PubMed ID: 9185715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of the intercellular adhesion molecule (ICAM-1) on squamous cell carcinoma by interferon gamma.
    Scher RL; Koch WM; Richtsmeier WJ
    Arch Otolaryngol Head Neck Surg; 1993 Apr; 119(4):432-8. PubMed ID: 8096142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of adhesion molecules in lymphokine-activated killer cell killing of bladder cancer cells: further evidence for a third ligand for leucocyte function-associated antigen-1.
    Jackson AM; Alexandrov AB; Prescott S; James K; Chisholm GD
    Immunology; 1992 Jun; 76(2):286-91. PubMed ID: 1353063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of IFN-gamma stimulation on expression of intercellular adhesion molecule-1 (ICAM-1) on alveolar macrophages in patients with non-small cell lung cancer.
    Dabrowska M; Grubek-Jaworska H; Hoser G; Domagała-Kulawik J; Krenke R; Chazan R
    J Interferon Cytokine Res; 2006 Mar; 26(3):190-5. PubMed ID: 16542141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of human melanoma cell ICAM-1 expression on lymphokine activated killer cell-mediated lysis, and the effect of retinoic acid.
    Alexander CL; Edward M; MacKie RM
    Br J Cancer; 1999 Jul; 80(10):1494-500. PubMed ID: 10408388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Different susceptibility of cervical keratinocytes containing human papillomavirus to cell-mediated cytotoxicity.
    Wu R; Coleman N; Stanley M
    Chin Med J (Engl); 1996 Nov; 109(11):854-8. PubMed ID: 9275369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stimulation of IFN-gamma, TNF-alpha, and TNF-beta secretion in IL-2-activated T cells: costimulatory roles for LFA-1, LFA-2, CD44, and CD45 molecules.
    Chong AS; Boussy IA; Graf LH; Scuderi P
    Cell Immunol; 1992 Oct; 144(1):69-79. PubMed ID: 1356634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.